Ask AI

PsA & Obesity: A Patient-Centered AI Simulation for Comprehensive Rheumatology Care

This activity is available for 0.50 CME/CE credit(s).

Released: August 14, 2026

Expiration: August 13, 2027

See Activity Collection

Xiomara Vega is a 39-year-old female presenting to her rheumatologist with persistent joint pain and stiffness despite ongoing treatment with a biologic medication.

Obesity is a clinically significant comorbidity in psoriatic arthritis, contributing to persistent inflammation, reduced biologic response, and increased cardiometabolic risk. Learners will explore how the bidirectional relationship between PsA and obesity shapes disease activity and practice integrating respectful, patient‑centered conversations and evidence‑based metabolic management into comprehensive PsA care.

PsA and Obesity

Pre Assessment: Prepare to Meet Your Patient

Assess your current knowledge and clinical approach before meeting your patient.
1.

How many people with psoriatic arthritis (PsA) and obesity do you provide care for in a typical month?​

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

A 52-year-old patient with PsA presents to his rheumatologist and is uncertain how talking about his weight will improve his PsA. Which approach would you use to address his uncertainties?

How confident are you in your answer?